Health Care

Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE Genworth Financial Inc., down $5.41 to $8.66 The financial services company reported a quarterly loss on higher costs, and the results fell short of Wall Street expectations.

Federal health officials have approved a daily pill that can cure the most common form of hepatitis C without the grueling pill-and-injection cocktail long used to treat the virus.

Wal-Mart will eliminate health insurance coverage for most part-time employees in a move aimed at controlling rising health care costs for the retailer.

South Dakota medical patients could have more choice of doctors within their health insurance networks if voters approve a ballot measure that is drawing strong opposition from the health insurance industry.

Health insurer Highmark Inc. has sued the University of Pittsburgh Medical Center claiming the hospital network has overbilled it by $300 million for cancer drugs.

Health insurer Highmark Inc. has sued the University of Pittsburgh Medical Center claiming the hospital network has overbilled it by $300 million for cancer drugs.

Health insurer Highmark Inc. and the Pennsylvania Insurance Department have spelled out a plan for Highmark customers to continue using doctors and some hospitals from the rival University of Pittsburgh Medical Center once Highmark's provider agreement with UPMC ends Jan. 1.

Attorney General Buddy Caldwell filed a lawsuit Tuesday against State Farm, alleging Louisiana's largest auto insurer is illegally steering customers involved in car accidents to repair shops that use junkyard parts and choose cheap fixes over safety.

Botox maker Allergan is suing a Canadian drugmaker and a hedge fund over their hostile takeover attempt, alleging insider trading and other fraud before their plan became public.

A $1,000-per-pill drug that insurers are reluctant to pay for has quickly become the treatment of choice for a liver-wasting viral disease that affects more than 3 million Americans.

Aetna Inc. (AET) on Tuesday reported profit that climbed by 2.4 percent in its second quarter, and topped analysts' expectations.

A costly drug given mostly to premature babies is at the center of a clash between the manufacturer and the nation's leading pediatrician's group, which recommends scaling back use of the medicine.

How much distance from an immoral act is enough?

Consumers and advocates urged state insurance regulators on Friday to deny a 12.5 percent rate increase proposed by Anthem Blue Cross and Blue Shield, Connecticut's largest health insurer.

American International Group Inc. swung to loss in the third quarter, falling short of Wall Street expectations as the giant insurer faces calls from shareholders Carl Icahn and John Paulson to break up.

Embattled Jefferies and Co. investment banker Sage Kelly has resigned amid a messy scandal.

Catalyst for Change: When former JPMorgan banker Ilan Ganot’s son was diagnosed with a rare form of muscular dystrophy, this father didn’t miss a beat to dedicate his life to saving his son’s.

The U.S. drug maker's shares advanced only modestly as Roche denied having a need to raise cash. 

Incyte Corp said it would discontinue some of the trials testing its already approved blood cancer drug, Jakafi, after the treatment's effectiveness was found to be insufficient.

AstraZeneca warned that revenue and earnings would drop this year due to the arrival of cheap generic rivals to its cholesterol fighter Crestor.